• S5 Ep79: Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

  • Dec 14 2023
  • Length: 11 mins
  • Podcast

S5 Ep79: Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Listen for free

View show details

  • Summary

  • In this episode of The Vitals, Beth Finley-Oliver, MSN, ARNP, AGNP-BC, a nurse practitioner who works in the outpatient hematology clinic at Moffitt Cancer Center, revisits her presentation from the 2023 JADPRO Live Annual Meeting and discusses the growing number of therapies for patients with relapsed or refractory multiple myeloma.

    Episode Highlights
    “A clinical trial upfront would be my first option. After that, I have to try and find something their myeloma hasn't seen yet.”

    “With CAR T, the CRS incidence is higher, and I think we're doing better [at managing it] because we have multiple interventions. We see viral infections with [both] the CAR T and the bispecifics. We always have to kind of keep that in the back of our mind.”

    “The more medications we have, the more this is turning into a chronic illness.”

     For More On Multiple Myeloma:

    • Delivering Teclistamab in the Outpatient Setting
    • Ambulation Improves Frailty Scores in Patients With Multiple Myeloma
    • With New Bispecific Antibodies in Multiple Myeloma, Nurses Need To Know How to Manage CRS


    Video Interviews

    • Managing Teclistamab-Induced CRS for Patients With Multiple Myeloma
    • Data Supporting Elranatamab Approval in Multiple Myeloma
    • Data Behind Talquetamab Approval in Multiple Myeloma

    More Podcast Episodes

    • Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape
    • ASH Data Offer Treatment Direction for Oncology Nursing Professionals
    • A Look Back at 2022 FDA Approvals in Oncology
    • Conversations Around Selinexor: Best Nursing Practices in Multiple Myeloma
    Show More Show Less
Show More Show Less

What listeners say about S5 Ep79: Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.